← Open Payments lookup

NICOLE SHEN: Open Payments

NPI 1073856027 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,405 in 45 payments from 14 companies in 2025. Trend: 2023 $1,439 · 2024 $2,843 · 2025 $1,405

Food & beverage: $1,405
CompanyPaymentsAmount
GENZYME CORPORATION3$212
PFIZER INC.8$210
Madrigal Pharmaceuticals4$182
ABBVIE INC.10$180
Boston Scientific Corporation3$153
CONMED Corporation2$139
Janssen Biotech, Inc.4$101
Takeda Pharmaceuticals U.S.A., Inc.2$44
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42
Aimmune Therapeutics, Inc.2$42

Products named: DUPIXENT, REZDIFFRA, CONMED BILIARY, EXALT Model D, VELSIPITY, XELJANZ, TREMFYA, RINVOQ.

Industry payments across MO — which companies pay providers there.